TY - JOUR
T1 - Salivary Gland Neoplasia in the Dog and Cat
T2 - Survival Times and Prognostic Factors
AU - Hammer, Alan
AU - Getzy, Dave
AU - Ogilvie, Greg
AU - Upton, Melinda
AU - Klausner, Jeff
AU - Kisseberth, William C.
PY - 2001
Y1 - 2001
N2 - Twenty-four dogs and 30 cats with histopathologically confirmed salivary gland neoplasia were retrospectively reviewed in a multi-institutional study. The predominant presenting complaint for animals with salivary gland neoplasia was that of a mass being noted by the owner; other common complaints included halitosis, dysphagia, and exophthalmia. Siamese cats were overrepre-sented, indicating a possible breed predisposition. The most common histopathological type was simple adenocarcinoma. Cats had more advanced disease at diagnosis than did dogs, and clinical staging was prognostic in dogs. The median survival times for dogs and cats were 550 days and 516 days, respectively.
AB - Twenty-four dogs and 30 cats with histopathologically confirmed salivary gland neoplasia were retrospectively reviewed in a multi-institutional study. The predominant presenting complaint for animals with salivary gland neoplasia was that of a mass being noted by the owner; other common complaints included halitosis, dysphagia, and exophthalmia. Siamese cats were overrepre-sented, indicating a possible breed predisposition. The most common histopathological type was simple adenocarcinoma. Cats had more advanced disease at diagnosis than did dogs, and clinical staging was prognostic in dogs. The median survival times for dogs and cats were 550 days and 516 days, respectively.
UR - http://www.scopus.com/inward/record.url?scp=0035462958&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035462958&partnerID=8YFLogxK
U2 - 10.5326/15473317-37-5-478
DO - 10.5326/15473317-37-5-478
M3 - Article
C2 - 11563448
AN - SCOPUS:0035462958
SN - 0587-2871
VL - 37
SP - 478
EP - 482
JO - Journal of the American Animal Hospital Association
JF - Journal of the American Animal Hospital Association
IS - 5
ER -